WallStreetZenWallStreetZen

NASDAQ: ISRG
Intuitive Surgical Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for ISRG

Based on 15 analysts offering 12 month price targets for Intuitive Surgical Inc.
Min Forecast
$318.00-17.77%
Avg Forecast
$407.80+5.46%
Max Forecast
$462.00+19.47%

Should I buy or sell ISRG stock?

Based on 15 analysts offering ratings for Intuitive Surgical Inc.
Strong Buy
Strong Buy
8 analysts 53.33%
Buy
4 analysts 26.67%
Hold
3 analysts 20%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ISRG stock forecasts and price targets.

ISRG stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-19Find Out Why
lockedlocked$00.00+00.00%2024-04-19Find Out Why
lockedlocked$00.00+00.00%2024-04-19Find Out Why
lockedlocked$00.00+00.00%2024-04-19Find Out Why
lockedlocked$00.00+00.00%2024-04-08Find Out Why
Citigroup
Top 8%
93
Strong BuyMaintains$462.00+19.47%2024-04-03Find out why
Mizuho
Top 12%
89
HoldMaintains$390.00+0.85%2024-01-25
Barclays
Bottom 5%
5
Strong BuyMaintains$430.00+11.20%2024-01-25
Raymond James
Top 17%
84
BuyMaintains$435.00+12.49%2024-01-25
RBC Capital
Bottom 13%
13
BuyMaintains$432.00+11.71%2024-01-24

1 of 2

Forecast return on equity

Is ISRG forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.17%

Forecast return on assets

Is ISRG forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

ISRG revenue forecast

What is ISRG's revenue in the next 3 years based on estimates from 11 analysts?
Avg 1 year Forecast
$8.0B+9.48%
Avg 2 year Forecast
$9.3B+26.59%
Avg 3 year Forecast
$10.7B+45.63%
ISRG's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ISRG earnings growth forecast

How is ISRG forecast to perform vs Medical Instruments & Supplies companies and vs the US market?
Company
-11.57%
Industry
23.04%
Market
17.22%
ISRG's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
ISRG's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
ISRG's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

ISRG revenue growth forecast

How is ISRG forecast to perform vs Medical Instruments & Supplies companies and vs the US market?
Company
13.23%
Industry
8.5%
Market
9.75%
ISRG's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ISRG's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ISRG vs Medical Stocks

TickerPricePrice TargetUp/downsideConsensus
ISRG$386.70$407.80+5.46%Strong Buy
BDX$235.67$289.00+22.63%Strong Buy
ALC$82.01$92.07+12.26%Strong Buy
RMD$213.82$209.14-2.19%Buy
WST$364.19$460.33+26.40%Strong Buy
View Top Medical Stocks

Intuitive Surgical Stock Forecast FAQ

Is Intuitive Surgical Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 15 Wall Street analysts covering (NASDAQ: ISRG) stock is to Strong Buy ISRG stock.

Out of 15 analysts, 8 (53.33%) are recommending ISRG as a Strong Buy, 4 (26.67%) are recommending ISRG as a Buy, 3 (20%) are recommending ISRG as a Hold, 0 (0%) are recommending ISRG as a Sell, and 0 (0%) are recommending ISRG as a Strong Sell.

If you're new to stock investing, here's how to buy Intuitive Surgical stock.

What is ISRG's revenue growth forecast for 2024-2026?

(NASDAQ: ISRG) Intuitive Surgical's forecast annual revenue growth rate of 13.23% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.5%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.75%.

Intuitive Surgical's revenue in 2024 is $7,318,500,000.On average, 11 Wall Street analysts forecast ISRG's revenue for 2024 to be $2,841,880,699,397, with the lowest ISRG revenue forecast at $2,804,658,934,554, and the highest ISRG revenue forecast at $2,870,634,217,446. On average, 11 Wall Street analysts forecast ISRG's revenue for 2025 to be $3,286,253,670,258, with the lowest ISRG revenue forecast at $3,247,402,741,574, and the highest ISRG revenue forecast at $3,367,399,721,157.

In 2026, ISRG is forecast to generate $3,780,460,326,169 in revenue, with the lowest revenue forecast at $3,682,526,758,127 and the highest revenue forecast at $3,931,204,625,226.

What is ISRG's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: ISRG) forecast ROA is N/A, which is lower than the forecast US Medical Instruments & Supplies industry average of N/A.

What is ISRG's Price Target?

According to 15 Wall Street analysts that have issued a 1 year ISRG price target, the average ISRG price target is $407.80, with the highest ISRG stock price forecast at $462.00 and the lowest ISRG stock price forecast at $318.00.

On average, Wall Street analysts predict that Intuitive Surgical's share price could reach $407.80 by Apr 19, 2025. The average Intuitive Surgical stock price prediction forecasts a potential upside of 5.46% from the current ISRG share price of $386.70.

What is ISRG's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: ISRG) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.